What's On

Jumar Bioincubator and the Monash Institute of Pharmaceutical Sciences have joined forces to host this full-day symposium, bringing together Melbourne's leading biotech professionals.

This is more than an event. It’s an opportunity to expand your expertise, connect with industry experts, and be part of the conversations shaping the future of drug development.

The symposium features over 15 speakers, including Professor Brendon Monahan (MedChem Australia), Professor Colin Pouton (Monash Institute of Pharmaceutical Sciences), Dr Kathy Nielsen (BioCurate), and Dr Heather Donaghy (Therapeutic Innovation Australia).

Tickets on sale now, secure your spot today.

Seed-stage founders in this room sit in the hardest part of the biotech funding gap. They have early data but are not yet “de-risked” by institutional VC standards. The gap between a $2.5M seed round and an $11M Series A is not just financial, it’s a shift in what investors expect, how capital is structured, and what data is required to progress. Globally, 66% of Australian startup deals now include at least one international investor, meaning local founders need to understand both landscapes. This masterclass is designed to give founders the frameworks, the vocabulary, and the candid perspectives they need to move from early data to a credible raise.